HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Clinical comparison of propoxyphene napsylate and methadone in the treatment of opiate dependence.

Abstract
In this double-blind comparison of propoxyphene napsylate (PN) 800 mg in two divided doses versus methadone 20 mg, methadone 10 mg or placebo methadone, it was found that PN: 1) did not alleviate withdrawal symptoms in patients previously maintained on methadone 20 mg; 2) produced a slightly overmedicated effect in the detoxified group of exmethadone patients; and 3) compared favorably to methadone 10 mg in suppressing withdrawal symptoms without producing evidence of overmedication in those patients previously stabilized on a methadone maintenance dose of 10 mg.
AuthorsR I Wang, C Kochar, A T Hasegawa, B L Roh
JournalNIDA research monograph (NIDA Res Monogr) Vol. 41 Pg. 253-60 (Apr 1982) ISSN: 1046-9516 [Print] UNITED STATES
PMID6126814 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Dextropropoxyphene
  • Methadone
Topics
  • Adult
  • Dextropropoxyphene (analogs & derivatives, therapeutic use)
  • Double-Blind Method
  • Heroin Dependence (rehabilitation)
  • Humans
  • Male
  • Methadone (therapeutic use)
  • Middle Aged
  • Random Allocation
  • Substance Withdrawal Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: